Skip to content
In-Person Scientific Forum

Oman Oncology

Pharmacy Value Forum 2026

Empowering Pharmacists for Value-Based Care

A scientific forum bringing together pharmacy and haematology expertise to address healthcare value, evolving treatment approaches, anticancer stewardship and practical considerations in the management of haematological malignancies.

Date
Saturday, 12 September 2026
Time
10:00 AM to 12:00 PM, Oman Time (GMT +4)
Venue
W Hotel, Muscat
Oman Pharmaceutical Society

Endorsed by

Oman Pharmaceutical Society

The forum starts in

00 Days
00 Hours
00 Minutes
00 Seconds

Saturday, 12 September 2026 · 10:00 AM to 12:00 PM Oman Time (GMT +4) · W Hotel, Muscat

Add to calendar

5

Expert Faculty

4

Scientific Sessions

2 Hours

Live and Interactive

Muscat

In Person at W Hotel

Why attend

Value-based cancer care, in practice

The Oman Oncology Pharmacy Value Forum 2026 is a focused, two-hour scientific programme for oncology pharmacists. Four expert-led sessions and a faculty-led interactive discussion connect clinical evidence to healthcare value, from national HTA guidelines to stewardship at the bedside.

Healthcare value

Applying Oman's National HTA Guidelines in everyday pharmacy practice, from clinical evidence to value.

Evolving treatment

A redefined CLL treatment landscape and the value of stabilization in PNH management.

Anticancer stewardship

Practical applications of stewardship across haematological malignancies.

Scientific focus

  • Health technology assessment
  • CLL treatment
  • Anticancer stewardship
  • PNH management
  • Faculty-led interactive discussion

Lunch will be served following the scientific programme.

Meet the experts

Faculty

Pharmacy, health technology assessment and haematology expertise from Oman and the wider region, leading four scientific sessions and an interactive discussion.

Dr. Muna Al Tarshi Opening and Closing Remarks

Dr. Muna Al Tarshi

Senior Consultant, Hematology and Bone Marrow Transplant

The Royal Hospital, Oman

Session

Welcome, Opening and Closing Remarks

Dr. Said Wani Speaker

Dr. Said Wani

HTA Specialist, Leading an HTA Project

Directorate General of Medical Supplies

Ministry of Health, Oman

Session

From Clinical Evidence to Healthcare Value: Applying Oman's National HTA Guidelines in Pharmacy Practice

Dr. Ahmed El-Sheashaey Speaker

Dr. Ahmed El-Sheashaey

Chief Hospital Oncology Pharmacist | Medication Safety Officer

Medication Use Evaluation Officer | Hospital Utilization Committee

Hospital Safety and Risk Management Committee Lead Officer

Co-Lead, KCCC Pharmacy Clinical and Specialty Unit

Kuwait Cancer Control Center (KCCC)

Session

Redefining CLL Treatment Landscape

Dr. Bushra Salman Speaker

Dr. Bushra Salman

Senior Specialist Pharmacist

National Hematology and Bone Marrow Transplant Center, University Medical City, Oman

Session

Anticancer Stewardship: Applications in Haematological Malignancies

Prof. Murtadha Al Khabori Speaker

Prof. Murtadha Al Khabori

Senior Consultant Hematologist

Sultan Qaboos University Hospital, Oman

Session

Advancing PNH Management: The Value of Stabilization

Opening and Closing Remarks

Dr. Muna Al Tarshi

Senior Consultant, Hematology and Bone Marrow Transplant

The Royal Hospital, Oman

Session

Welcome, Opening and Closing Remarks

Biography

Dr. Muna Al Tarshi is a Senior Consultant at the Royal Hospital, Muscat. She earned her MD from Sultan Qaboos University and completed Internal Medicine and Hematology training at McGill University, obtaining FRCPC and American Board certifications. She completed a Bone Marrow Transplant fellowship at Princess Margaret Cancer Centre, University of Toronto. Her practice focuses on lymphoma, plasma cell myeloma, and autologous stem cell transplantation. She is Associate Program Director at the Oman Medical Specialty Board and Treasurer of the Omani Society of Hematology.

Speaker

Dr. Said Wani

HTA Specialist, Leading an HTA Project

Directorate General of Medical Supplies

Ministry of Health, Oman

Session

From Clinical Evidence to Healthcare Value: Applying Oman's National HTA Guidelines in Pharmacy Practice

Biography

Dr. Said Wani is an experienced health economist and PhD candidate in Health Technology Assessment (HTA) at Semmelweis University in Hungary. With a background in Pharmacy and advanced training in Pharmacoeconomics and Health Economics, he earned an MSc in International Health Economics from Cardiff University in the UK. Over the past 19 years at the Ministry of Health in Oman, he has held major leadership roles, including Director of Medical Supplies and Director of Pharmaceutical Procurement. His expertise covers pharmaceutical procurement, medical device management, quality systems (including ISO 13485), strategic planning, and HTA. He actively participates in implementing HTA in Oman, contributing to national guidelines, cost-effectiveness thresholds, and stakeholder engagement processes. As a member of ISPOR, HTAi and the GCC Health Economists Association, Said is dedicated to promoting evidence-based decision-making and building sustainable healthcare systems through education, collaboration, and policy reform.

Speaker

Dr. Ahmed El-Sheashaey

Chief Hospital Oncology Pharmacist | Medication Safety Officer

Medication Use Evaluation Officer | Hospital Utilization Committee

Hospital Safety and Risk Management Committee Lead Officer

Co-Lead, KCCC Pharmacy Clinical and Specialty Unit

Kuwait Cancer Control Center (KCCC)

Session

Redefining CLL Treatment Landscape

Biography

Dr. Ahmed El-Sheashaey is the Chief Hospital Oncology Pharmacist and Medication Safety Officer at the Kuwait Cancer Control Center (KCCC). Since joining in 2008, he has led major initiatives in chemotherapy and immunotherapy protocol development, hospital safety leadership, and multidisciplinary cancer care. He holds certifications in patient safety, sterile compounding, medication safety, and specialty pharmacy in oncology and hematology. As Staff Development Officer since 2012, he oversees pharmacist training and clinical competency development. Ahmed also contributes to research, abstracts, and pharmacoeconomics, and plays a leading role in establishing Kuwait's first clinical and specialty oncology pharmacy service, supporting the transition to KCCC's new, future-ready facility.

Speaker

Dr. Bushra Salman

Senior Specialist Pharmacist

National Hematology and Bone Marrow Transplant Center, University Medical City, Oman

Session

Anticancer Stewardship: Applications in Haematological Malignancies

Biography

Dr. Bushra Salman is a senior American Board-certified oncology pharmacist. She holds an MPharm degree from the University of Strathclyde, UK, and an MSc in Clinical Pharmacy from Sultan Qaboos University. She is a Senior Specialist Pharmacist at the National Hematology and Bone Marrow Transplant Center, University Medical City. She has led key initiatives in clinical pharmacy services and formulary management and is an active researcher in cancer medicine.

Speaker

Prof. Murtadha Al Khabori

Senior Consultant Hematologist

Sultan Qaboos University Hospital, Oman

Session

Advancing PNH Management: The Value of Stabilization

Biography

Prof. Murtadha Al Khabori is Professor of Hematology at Sultan Qaboos University and Senior Consultant Hematologist at University Medical City, Oman. He trained in hematology and bone marrow transplantation in Toronto and in research at McMaster University.

Scientific programme

Programme

Saturday, 12 September 2026 · 10:00 AM to 12:00 PM Oman Time (GMT +4) · W Hotel, Muscat

  1. 10:00 to 10:05 AM 5 min

    Welcome and Opening Remarks

    Dr. Muna Al Tarshi

  2. 10:05 to 10:30 AM 25 min

    From Clinical Evidence to Healthcare Value: Applying Oman's National HTA Guidelines in Pharmacy Practice

    Dr. Said Wani

  3. 10:30 to 10:50 AM 20 min

    Redefining CLL Treatment Landscape

    Dr. Ahmed El-Sheashaey

  4. 10:50 to 11:15 AM 25 min

    Anticancer Stewardship: Applications in Haematological Malignancies

    Dr. Bushra Salman

  5. 11:15 to 11:35 AM 20 min

    Advancing PNH Management: The Value of Stabilization

    Prof. Murtadha Al Khabori

  6. 11:35 to 11:55 AM 20 min

    Interactive Discussion (Faculty-Led)

    All faculty

  7. 11:55 AM to 12:00 PM 5 min

    Closing Remarks

    Dr. Muna Al Tarshi

  8. 12:00 PM onwards

    Lunch

Venue

W Hotel, Muscat

Al Kharjiya Street, Shatti Al Qurum
Muscat 103, Sultanate of Oman

When
Saturday, 12 September 2026
10:00 AM to 12:00 PM, Oman Time (GMT +4)
Format
In-Person Scientific Forum
Scientific programme followed by lunch

Registration

Reserve your seat

Join oncology pharmacists and haematology experts in Muscat on 12 September 2026. Register to secure your place at the forum.

  • In-person scientific forum
  • Faculty-led interactive discussion
  • Lunch to follow

Endorsed by

Oman Pharmaceutical Society

Sponsored by

AstraZeneca

Managed by

Meeting Minds Experts